NCT02571998View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

PHASE2CompletedINTERVENTIONAL

Enrollment

320

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Acne Vulgaris

Interventions

DRUG

Omiganan (CLS001) Topical Gel

DRUG

Vehicle Topical Gel

Trial Locations (29)

Unknown

Mobile

Phoenix

Santa Ana

Santa Monica

Denver

Boca Raton

Boynton Beach

Miami

Pinellas Park

Sanford

Tampa

Beverly

Fort Gratiot

St Louis

Las Vegas

Newington

Albuquerque

New York

Stony Brook

High Point

Raleigh

Knoxville

Arlington

Austin

Pflugerville

San Antonio

Webster

Salt Lake City

Spokane

All Listed Sponsors

lead

Maruho Co., Ltd.

INDUSTRY

NCT02571998 - A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris | Biotech Hunter | Biotech Hunter